Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes

Annals of Oncology

Volumn 24, Issue 11, 2013, Pages 2794-2801

  van der Heiden van der Loo, M ^a   Schaapveld, M ^a,b   Ho, V K Y ^a   Siesling, S ^a,c   Rutgers, E J T ^b   Peeters, P H M ^d  

^a Department of Cancer Registry and Research   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adjuvant therapy; Breast cancer; Cancer recurrence; Isolated tumour cells; Micrometastases; Sentinel node

Indexed keywords

ANTINEOPLASTIC AGENT; TRASTUZUMAB;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EARLY CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MICROMETASTASIS; PARTIAL MASTECTOMY; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME;

ADJUVANT THERAPY; BREAST CANCER; CANCER RECURRENCE; ISOLATED TUMOUR CELLS; MICROMETASTASES; SENTINEL NODE;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 84887119870     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt243     Document Type: Article

References (26)

1. Giuliano AE, Kirgan DM, Guenther JM et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-398.
2. Krag DN, Weaver DL, Alex JC et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
3. Veronesi U, Viale G, Paganelli G et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010; 251: 595-600.
4. Roumen RM, Pijpers HJ, Thunnissen FB et al. Summary of the guideline 'Sentinel node biopsy in breast cancer.' Dutch Work Group 'Sentinel Node Biopsy for Breast Cancer'. Ned Tijdschr Geneeskd 2000; 144: 1864-1867.
5. Krag DN, Anderson SJ, Julian TB et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 927-933.
6. Pepels MJ, Vestjens JH, de Boer M et al. Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat 2011; 125: 301-313.
7. van der Heiden-van der Loo M, Bezemer PD, Hennipman A et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol [2006;] 32: 710-714.
8. Maaskant AJ, van de Poll-Franse LV, Voogd AC et al. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 2009; 113: 173-179.
9. de Boer M, van Dijck JA, Bult P et al. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst [2010;] 102: 410-425.
10. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 2007; 14: 3378-3384.
11. Colleoni M, Rotmensz N, Peruzzotti G et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005; 23: 1379-1389.
12. Weaver DL, Ashikaga T, Krag DN et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 2011; 364: 412-421.
13. Gobardhan PD, Elias SG, Madsen EV et al. Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol [2011;] 18: 1657-1664.
14. Hansen NM, Grube B, Ye X et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 2009; 27: 4679-4684.
15. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat 2011; 127: 195-203.
16. de Boer M, van Deurzen CH, van Dijck JA et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361: 653-663.
17. Sobin LH, Wittekind C (eds). TNM Classification of Malignant Tumors. International Union Against Cancer (UICC). New York: Wiley-Liss, 2002.
18. Degnim AC, Zakaria S, Boughey JC et al. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]. Ann Surg Oncol 2010; 17: 2685-2689.
19. Galimberti V, Botteri E, Chifu C et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat 2012; [131:] 819-825.
20. Giuliano AE, McCall L, Beitsch P et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group [0011Z] randomized trial. Ann Surg 2010; 252: 426-432.
21. Giuliano AE, Hunt KK, Ballman KV et al. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305: 569-575.
22. Viehl CT, Langer I, Guller U et al. Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J Surg Oncol 2011; 103: 531-533.
23. Yi M, Giordano SH, Meric-Bernstam F et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 2010; 17(Suppl 3): 343-351.
24. Bilimoria KY, Bentrem DJ, Hansen NM et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009; 27: 2946-2953.
25. Haibe-Kains B, Desmedt C, Piette F et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 2008; 9: 394.
26. Bosco JL, Silliman RA, Thwin SS et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 2010; 63: 64-74.